Platelet Thrombi in Rejection Episodes Biopsies of kidneys taken during rejection episodes have been shown to contain aggregates of platelets in the transplanted vessels (Porter 1967 ). These aggregates are not normally found at other times, except in those transplanted kidneys which show the effects of preformed antibody, and are rejected in the first few hours after transplantation. The recipients of kidneys showing this 'hyperacute rejection' may have demonstrable circulating antibody (Kissmeyer-Nielsen et al. 1966) . Such antibody may be formed as a result of sensitization by blood transfusion, pregnancy or a previous transplant. In the absence of such sensitization it takes some days after transplantation for the development of antibody, and rejection episodes are not found as early with first transplants as they are in patients with second grafts. It appears that the episodes are caused by the humoral antibody.
Since the demonstration that platelet aggregation in vitro could be initiated with immune complex (Movat et al. 1965 ) it has been possible to put forward a hypothesis to explain the rejection episode. This would suggest that antibody in the graft vessels, attached to transplantation antigens, would cause adherence of platelets with release of ADP which would aggregate normal platelets in the transplant vessels. When this aggregation was extensive it would be recognized clinically as a rejection episode. We have been able to show that the platelet count falls at the start of many rejection episodes, and that successful treatment of the episode is nearly always associated with a measurable rise in peripheral platelet count. When the patient's platelets were labelled with 51Cr and reinfused on the fourth day after transplantation, the labelled platelets disappeared from the blood at the start of the episode, and radioactivity, measured by external counting, accumulated in the kidney. These changes were both reversed by treatment with increased dosage of azathioprine and steroids. Both 6-mercaptopurine and hydrocortisone were shown to be able to prevent the release of ADP from platelets which had adhered to immune complex in vitro, but actinomycin. C, which has been used to treat rejection episodes in some centres, was found to be quite inactive.
[The work described in this paper has been published in preliminary form (Mowbray 1966 Patients treated with steroids and other immunosuppressive agents are particularly susceptible to infections. In many reports of renal transplanta-tion experiences, infections have been the major contributing factors to death (Rifkind 1964 , Slapak et al. 1968 , Caine et al. 1964 , Mowbray et al. 1965 , Hume et al. 1955 Many bizarre infections associated with viruses, fungi and protozoans have been reported by Hedley-Whyte & Craighead (1965) , Rifkind et al. (1967) , Hume et al. (1966) , Rifkind (1965 ), Park et al. (1967 , Russell (1968 ), Hill et al. (1964 and Evans et al. (1968) .
Treatment with corticosteroids and azathioprine was common to all series. The need for intensive antibiotic therapy in many instances was associated with the emergence of resistant bacterial strains and viral and fungal proliferation. This is a report on a series of 55 patients who received 62 renal transplants. Fifty-nine were from cadaveric sources and 3 from related live donors. All patients were treated with steroids and azathioprine, as from the time of renal transplantation. Pre-operative management consisted of hmmodialysis with Kiil kidneys using single pass warm dialysate supply for 28-30 hours weekly. Peritoneal dialysis had been performed in some cases. Thirty-five patients developed significant infections. Infection was a major contributory cause of death in 16 of these patients, 12 of whom had undergone allograft rejection and had been given antirejection therapy.
Septicwmia
Septiczmia occurred in 18 patients, one of whom had three separate episodes. In 4 cases where the donors had been on respirators for more than 48 hours, infection was transferred from the donor to the recipient at transplantation. Two of these patients subsequently developed secondary hemorrhages from abscess formation at the arterial anastomotic sites. In one pair of patients the organism was a coliform bacillus and in the others a Pseudomonas aeruginosa. In 4 patients septicwemias occurred secondary to infections in Scribner shunt sites: Staphylococcus aureus in 3 and Candida albicans in one.
The commonest infecting organisms in this series were coliform bacilli, Ps. aeruginosa and Staphylococcus aureus. Klebsiella spp, nonhtemolytic streptococci, Proteus spp, Listeria monocytogenes and C. albicans occurred in isolated instances. All 5 patients with Ps. aeruginosa septicxemias died even though the organism was eradicated from the blood stream in all cases prior to death. Four out of 5 with staphylococcal septicemias survived. One patient developed L. monocytogenes septicxmia and meningitis 7 weeks after transplantation. He had undergone three rejection episodes and had been treated with high doses of steroids.
Urinary Tract
Sixteen patients had Escherichia coli infections in the urine pre-operatively. Seven of these were subjected to bilateral nephrectomy prior to transplantation and only 2 (28 %) developed significant urinary E. coli infections after transplantation. Of the 9 who did not undergo bilateral nephrectomy, urinary E. coli infections occurred in 6 (66 %), 4 of whom were undergoing rejection. In 12 patients who did not show pre-transplant E. coli urinary infections the organism appeared postoperatively; in 9 cases these were associated with rejection and in 2 with urinary tract obstruction.
Ps. aeruginosa infection was not present in the urine of any pre-operative patient. However, in 6 patients after transplantation it appeared. Only one of these patients had had bilateral nephrectomy prior to transplantation. In 3 patients the Ps. aeruginosa appeared at the time of rejection and in 2 it appeared following episodes of Ps. aeruginosa septicemia.
Lungs
In this series 15 patients developed infective pulmonary complications; 8 of these died and 4 had evidence of bacterial bronchopneumonia. Three patients who were undergoing allograft rejection appeared to develop a syndrome similar to that described as 'transplant pneumonia', i.e. severe dyspncea and unproductive cough with few or no abnormal clinical signs in the chest, arterial gas changes compatible with an alveolar capillary diffusion block and scattered fine opacities in the lung fields on X-ray. A mixture of bacteria was grown from the sputa of these patients, all of whom died. At autopsy, fibrous thickening and epithelialization of the alveolar walls, intra-alveolar hmmorrhage, zones of necrosis and abscess formation were found, the atscesses containing fungal hyphw, bacteria and necrotic tissue.
A fourth patient who fitted into the clinical picture of 'transplant pneumonia' did not undergo rejection, and by rapidly reducing the dose of immunosuppressive drugs, his pulmonary symptons cleared completely.
Wounds
Wound infections occurred in 32 patients, the commonest organism being Staphylococcus aureus which occurred in 40 % of nasal carriers. Staphylococcal wound infections also occurred in 5 patients who were not nasal carriers of Staph. aureus. Three patients with E. coli wound infections had developed pelvic abscesses as a result of urinary leakage from the bladder and the same organisms were found at both sites. Section ofMedicine with Section ofClinical Immunology and Allergy 599
One patient developed a post-anmsthetic aspiration pneumonia and subsequently a lung abscess. After a stormy course during which the abscess was drained and appropriate antibiotic and antifungal treatment given, he recovered completely and one year later a bronchiectatic segment of the right lower lobe was successfully resected.
Active tuberculosis has not occurred in any of our patients though one had healed pulmonary tuberculosis. He was given anti-tuberculous prophylaxis.
Lepromatous leprosy occurred in one patient two years after transplantation. We discovered subsequently that he had suffered from leprosy during childhood but after 10 years he had discontinued his treatment. He presented with fever, erythema nodosum leprosum, nerve thickening and epididymo-orchitis. The diagnosis was confirmed by skin biopsy. Signs and symptoms disappeared promptly when he was started on a small dose of dapsone.
Viruses
Herpes simplex infection was recognized during life in 6 patients, 3 of whom presented with corneal ulceration. The others suffered from severe oral ulceration during periods when they were undergoing rejection and were being treated with high steroid doses. Herpes zoster occurred in 3 cases and all recovered completely. One patient developed fulminating hemorrhagic varicella probably transmitted from a patient with herpes zoster with whom she had been in contact at a time when she was on high doses of steroids. She died four days after the appearance of rash and at post-mortem there was evidence of widespread dissemination of the virus.
Seven patients developed evidence of hepatic dysfunction. One became jaundiced four months after losing his first transplant due to hxemorrhage and recovered completely. The other 6 patients had all been transplanted and were on immunosuppressive therapy. Only one of the latter group survived and from histological examination of the livers no one factor could be held responsible but cytomegalic inclusion bodies and herpes simplex virus were found in the tissues of all but one of these patients.
Fungal Infections
The appearance of fungal organisms during the post-transplantation period in 'this series was associated in every instance with either antirejection therapy or intensive antibiotic therapy or a combination of both. Prophylactic antibiotic treatment was not given for this reason. An attempt was made to recognize pre-operatively carriers of C. albicans by means of throat, rectal and perineal swabs. Eleven patients were found on admission to be harbouring C. albicans in their throats and 6 of these subsequently developed severe cesophageal pain on swallowing which was unrelieved by milk or alkalis. In all cases relief of symptoms occurred with small doses of amphotericin B intravenously. Prophylactic oral nystatin or amphotericin B is ncw given routinely with virtual disappearance of oral or oesophageal symptoms. Urinary moniliasis were found in 12 post-transplant cases, 6 men and 6 women. In 6 cases there was evidence of renal failure and 10 patients had been treated with antibiotics for bacterial urinary tract infections.
C. albicans was found in the respiratory tract of only 2 patients, one of whom had a lung abscess secondary to an inhalation pneumonia. One patient developed systemic moniliasis from a Scribner shunt. This was eradicated by removal of the shunt and the administration of amphotericin B intravenously.
Post-mortem Findings
Post-mortem examinations were carried out on twenty of these patients and all were performed within three hours of death. In 15 cases fungal infections were found histologically, in some cases confirmed by culture.
C. albicans was found in the lungs of 5 patients, in the cesophagus in 4 (related to nasogastric intubation in 2 of these) and kidneys in 2.
Aspergillusfumigatus was found in the lungs of 7, the brains of 3 and the prostate and kidney in 1 each.
Torulosis was found in the brain and allograft of one patient. Cytomegalovirus inclusion bodies were found in 6 casesdisseminated through the lungs, oesophagus, lymph nodes, allografts, kidneys, duodenum and liver and the cytomegalovirus was grown from the lungs in 2 cases.
Herpes simplex was grown from 2 livers, and varicella virus from the lungs and allograft of one patient. ECHO 4 virus was cultured from the lungs of one patient.
Conclusions
From this review of infections occurring in patients who were on immunosuppressive therapy after renal transplantation, several tentative conclusions may be drawn:
(1) Patients harbouring pathogenic organisms in the nasopharynx and urinary tract were especially prone to develop significant infections when exposed to immunosuppressive drugs.
(2) Infections were often associated with allograft rejection.
(3) Antibiotic therapy was often associated with fungal and viral infections. (4) The presence of widespread fungal and viral infections seen at autopsy was in nearly all cases associated with irreversible rejection in combination with bacterial infections. In many of these cases, fungi and viruses had not been found during life.
In an attempt to avoid these life-threatening infections, it would seem logical, therefore:
(1) To treat patients who are carriers of organisms with local antibiotics or antifungal agents preoperatively and to remove the kidneys in those who have had or who might be likely to develop urinary tract infections.
(2) Not to give prophylactic antibiotics but to treat infections as they arise with the appropriate antibiotic.
(3) In the event of severe infection with rejection, to remove the allograft, discontinue immunosuppressive drugs and restore the patient on to hamodialysis prior to a second transplant.
